(Q50514904)

English

Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine.

scientific article published in May 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

author name string

V De Sanctis

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

A Pinamonti

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

A Di Palma

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

M Sprocati

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

G Atti

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

M R Gamberini

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

C Vullo

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

publication date

1 May 1996

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

European Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

155

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

368-372

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

Ocular changes in patients undergoing long-term desferrioxamine treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth Failure and Bony Changes Induced by Deferoxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron-Loaded Subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Cooley's anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deferoxamine-induced growth retardation in patients with thalassemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deferoxamine-induced bone dysplasia in patients with thalassemia major

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Auditory Involvement in Thalassemia Major

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth velocity in thalassemic children receiving different protocols of chelating therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of excessive liver iron stores with desferrioxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular toxicity of high-dose intravenous desferrioxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741032

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S004310050419

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/8741032

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50514904&oldid=1483181183"